|
Mechanismβ-glucuronidase inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Optimization of skin preparation to reduce Cutibacterium acnes colonization in superficial and deep samples during prosthetic shoulder surgery in male patients - OPRICA
100 Clinical Results associated with Firmicute infection
100 Translational Medicine associated with Firmicute infection
0 Patents (Medical) associated with Firmicute infection